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ABSTRACT
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Nutrient availability regulates eukaryotic cell growth. This study focuses on two
signaling pathways, involved in sensing amino acids and carbon sources, which allow
cells to respond appropriately to their presence. The first part of this study shows that
Ssy1, a plasma membrane localized sensor in the Ssy1-Ptr3-Ssy5 (SPS) amino acid

Deleted: Nutrients such as glucose
and amino acids activate signal
transduction pathways to allow cells
to respond appropriately to their
presence.
Deleted: s
Deleted: respectively
Deleted: amino

sensing pathway, can detect 19 common L-amino acids with different potencies and
affinities based on the physiochemical structure of amino acids. Substituents around
alpha carbon are critical for amino acid sensing by Ssy1. Furthermore, a high
concentration of cysteine is toxic to cells. Inactivation of SPS signaling confers resistance
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to cysteine. The second part focuses on the regulation of Hap4, the regulatory subunit
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Mediator complex negatively regulate HAP4 expression. Srb8 undergoes post-
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translational modification in response to changes of the carbon source. Gal11 and Med3
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positively regulate HAP4 expression.
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CHAPTER 1: GENERAL INTRODUCTION
Saccharomyces cerevisiae, commonly known as Baker’s yeast, requires nutrients to
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survive. There are several different environmental nutrient sources, such as carbon
sources and nitrogen sources, utilized by yeast for cellular metabolic processes. Two
signal transduction pathways in yeast that sense amino acids and glucose respectively
are studied here.
Formatted: Indent: First line: 0.5"

The SPS Amino Acid Sensing Pathway in Yeast
Formatted: Line spacing: 1.5 lines

Amino acids are nutrients for cellular metabolic processes. In the presence of
environmental amino acids, the Ssy1-Ptr3-Ssy5 (SPS) amino acid signaling pathway is
activated and enables yeast cells to import extracellular amino acids [1-3]. Ssy1 is a
homolog of functional amino acid permeases and consisted of 12 transmembrane
helices and an N-terminal signaling domain (Figure 1) [4]. Amino acids binding to Ssy1
initiate the signaling pathway [1, 5]. After sensing amino acids, the N-terminal
signaling domain of Ssy1 has been proposed to recruit two casein kinase I proteins,
Yck1 and Yck2, resulting in hyperphosphorylation of the peripheral plasma membrane
protein Ptr3 [6-8]. Ssy5, a peripheral membrane protein and a chymotrypsin-like serine
protease, associates with Ptr3 to form a complex [3]. Ssy5 undergoes autocatalytic
processing to generate an N-terminal prodomain and a C-terminal catalytic domain,
which remain associated. When the N-terminal prodomain is phosphorylated, it is
degraded through the ubiquitin/proteasome system, resulting in the activation of the Cterminal catalytic domain. The active catalytic domain removes an N-terminal
inhibitory domain from two zinc finger transcription factors, Stp1 and Stp2, resulting in
their activation [6, 9, 10]. Processed Stp1 and Stp2 then translocate from the cytoplasm
into the nucleus to activate target gene expression (Figure 1) [11]. The yeast genome
encodes about 24 amino acid permeases [12, 13]. Expression of seven amino acid
1

permeases, Bap2, Bap3, Agp1, Gnp1, Tat1, Tat2, and Mup1, is induced by extracellular
amino acids through the activation of the SPS signaling pathway [1, 4, 14-16].
Expression of these amino acid permeases on the plasma membrane allows amino acid
uptake.
Other proteins are also involved in SPS signaling. The effect of Yck1/2 can be
reversed by the Rts1-containing subcomplex of the trimeric protein phosphatase type
2A [7]. Grr1 is the F box-containing component of the SCF Grr1 E3 ubiquitin ligase
complex, which is required for degradation of the N-terminal prodomain of Ssy5 and
activation of the C-terminal catalytic domain of Ssy5 [4, 7]. Dal81 is a pleiotropic
transcription factor that is essential for full activation of Stp1/2-target gene expression
[17]. Shr3, an amino acid permease-specific packaging chaperone in the membrane of
the endoplasmic reticulum (ER), regulates the SPS signaling pathway by mediating ER
exit of amino acid permeases and possibly Ssy1 [3, 18].
Previously, amino acid sensing by Ssy1 was studied using fixed amino acid
concentrations [4, 19, 20]. It is unclear as to the relative affinity and potency of 20 amino
acids on Ssy1. In this study, I aim to address this question.

2
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Figure 1: Illustration of Ssy1-Ptr3-Ssy5 amino acid sensing pathway
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The second signal transduction pathway addressed in this study is related to
mitochondrial biogenesis. Mitochondria are the cellular power plants where ATP is
produced. Mitochondrial biogenesis in S. cerevisiae is regulated in part by the CCAATbinding factors, the Hap2/3/4/5 complex. Eukaryotic messenger RNA synthesis in
response to changing environments can be initiated by the binding of RNA Polymerase
II, along with general transcription factors (GTFs such as TFIIA, TFIIB, TFIID, TFIIE,
TFIIF, and TFIIH), to the promoter sequences of target genes. Transcription factors are
sequence-specific DNA-binding proteins that are needed for transcriptional regulation
[21]. CCAAT-binding proteins are transcriptional activators that promote expression of
3

target genes by interacting with CCAAT sequence motifs in target gene promoters [22].
S. cerevisiae can grow in either fermentative (glucose) or nonfermentative (ethanol,
glycerol, lactate, etc.) carbon sources. In cells grown in the presence of a
nonfermentative carbon source such as ethanol, the Hap2/3/4/5 complex activates
expression of genes required for respiratory metabolism [23-28]. It has been reported
that Hap2, Hap3, and Hap5 are constitutively expressed and form a complex at the
promoters of target genes. Hap4 expression is at basal levels in cells grown in glucose
medium, and its expression is greatly induced in cells grown in non-glucose medium
[29].
Hap4 is a protein of 554 amino acids. It contains two transcriptional activation
domains: one is a Gcn5- independent at the C-terminus between amino acid residues
359 and 476; the other is Gcn5-dependent at the N-terminus between amino acid
residues 124 and 329 [30]. While Hap2/3/5 heterotrimer binds to targeted DNA, Hap4 is
the main regulatory subunit of Hap complex by binding and activating the entire
complex, and its protein level determines the activity of this complex.
Formatted: Indent: First line: 0.5"
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The Mediator complex is a 25-protein complex that plays important roles in gene
expression [31-33]. Its interaction with both transcription factors and RNA Polymerase
II can increase gene expression [32]. The Mediator complex is conserved and exists in all
eukaryotic organisms [34, 35]. The Mediator complex can be divided into four groups:
head, middle, tail, and kinase modules (Figure 2) [36, 37]. The head module consists of
eight subunits, Med6, Med8, Med11, Srb4/Med17, Srb5/Med18, Rox3/Med19,
Srb2/Med20 and Srb6/Med22 [38]. Electron microscopy shows that the Mediator head
module closely associates with the Rpb3/Rpb11 heterodimer of RNA Pol II, the
Rpb4/Rpb7 subunits, and TBP [39, 40]. The subcomplex Med18/20 is responsible for
4

conformational changes of the head module, which allows the interaction between the
Mediator complex and RNA Pol II [40].
The middle module, which includes eight subunits, Med1, Med4, Nut1/Med5,
Med7, Cse2/Med9, Nut2/Med10, Srb7/Med21 and Soh1/Med31, is elongated and flexible
and contributes to one third of the length of the entire mediator complex[41]. The
Med7/Med21 interface contains a four-helix bundle domain and a coiled-coil protrusion
connected by a flexible hinge, and Med 6 is the bridge connecting the head and middle
modules[42],. Med6, Med7, and Med21 are responsible for the mediator complex
conformational changes at the interface of the head and middle modules upon binding
of RNA Pol II.
The tail module contains five subunits, Med2, Pgd1/Med3, Rgr1/Med14,
Gal11/Med15 and Sin4/Med16 [43]. Two-hybrid and glutathione S-transferase
interaction assays showed that the Med3 subunit negatively regulates transcription by
associating directly with the Cyc8-Tup1 transcription co-repressor [44]. It was shown
that Med2, Med3, and Gal11 form a triad that can be recruited to transcription activator
Gcn4p independently without interfering with Sin4 [45].
The kinase module is composed of four subunits, Med12/Srb8, Med13/Srb9,
Srb11 and Cdk8/Srb10 [46, 47]. In an early study, it was suggested that Srb10 repressed
activation of genes that enable cells to survive under nutrient deprivation, and Srb10
expression is greatly reduced when cells enter the diauxic shift [48]. By observation of
strong defects in Gal4-activated transcription in an srb9 mutation strains, it was shown
that the kinase module, Srb8-Srb11, is directly involved in GAL1 transcription. The
binding of Srb9 at the GAL1 gene promoter region induces the recruitment of TBP [49].

5

HAP4 expression is increased approximately ten-fold when yeast cells are grown
in raffinose medium compared to dextrose media. Despite the importance of
mitochondria in cellular metabolism and the essential role of Hap4 in mitochondrial
biogenesis, the regulatory mechanism of HAP4 expression is still unclear. The Mediator
complex component Sin4 and Cyc8, a general transcriptional co-repressor, have been
shown in our lab to be negative regulators of HAP4 expression. However, how the
Mediator complex regulates HAP4 expression is still unknown.

Figure 2: A structure model of the Mediator complex
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Research Aims
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The Ssy1 amino acid sensor of the SPS signaling pathway is a functional homolog
of amino acid permeases. Ssy1 has been shown to have a broad specificity for amino
acids [4]. However, there has not been a systematic study done to address the binding
affinity of activity of individual amino acids on Ssy1. I hope to address the issue in this
study. In the glucose sensing pathway, the expression of HAP4 is not well understood. I
aim to address the role of individual Mediator complex components on HAP4
expression.

7

CHAPTER 2: AMINO ACID STRUCTURE DIFFERENTIALLY
AFFECTS THE SSY1-PTR3-SSY5 AMINO ACID SENSING
PATHWAY
Introduction
The Ssy1-Ptr3-Ssy5 (SPS) amino acid signaling pathway in S. cerevisiae responds
to and induces the uptake of extracellular amino acids [1-3]. When amino acids bind to
the Ssy1 sensor on the plasma membrane, Yck1/2 are recruited and phosphorylates Ptr3
and Ssy5, leading to activation of the C-terminal catalytic domain of Ssy5. Activation of
Ssy5 enables processing of Stp1 and Stp2 and their subsequent translocation into the
nucleus to activate target gene expression [1, 3, 6-9, 11]. There have been no systematic
amino acid titration studies performed to determine the affinity and potency of
individual amino acids on Ssy1. There has also been no careful analysis of whether the
physical characteristics of amino acids affect Ssy1 sensing. In this study I subjected yeast
cells to titrations of individual amino acids and determined the activity of the SPS
amino acid signaling pathway using an AGP-lacZ reporter gene. Both L- and Disoforms of the amino acids were used as well as structural isoforms that have
alterations on substituents around the alpha carbon in an effort to characterize the effect
of physiochemical differences on SPS amino acid sensing.
Materials and Methods
Strains, Primers, Plasmids, Growth Media and Growth Conditions
Yeast strains, primers, and plasmids used in this study are listed in Table 1, Table
2, and Table 3, respectively. Yeast cells were grown at 30°C in SD medium (0.67% yeast
nitrogen base and 2% D-glucose) or YPD (2% peptone, 1% Bacto-yeast extract, and 2%
D-glucose). The amino acids L-leucine, L-lysine, L-histidine, L-methionine, L8

tryptophan, and/or uracil were added to growth media to a final concentration of 30
mg/L to meet auxotrophic requirements [50]. Solid media contained 2% agar in addition
to the components described above when needed.
Yeast Transformations and β-galactosidase Activity Assays
Yeast cells were transformed [51]. Liquid cultures were inoculated with a pool of

Formatted: Indent: First line: 0.5",
Line spacing: 1.5 lines

several independent transformants and grown overnight in SD medium with specified
amino acids to an optical density at 600 nm of ~0.6. The cell extracts were prepared by
using glass bead lysis method. 10 – 90 mL of clear cell extract of independent samples
were objected to β-galactosidase assays, hydrolyzing o-nitrophenyl-β-Dgalactopyranoside (ONPG) [50]. Protein concentration of individual sample was carried
out by performing Bradford assay, using bovine serum albumin as the standard.
Reporter gene activity was calculated in nmoles of hydrolyzed ONPG per minute per
mg of protein Assays were conducted in duplicate and independent experiments were
carried out two to three times.
Formatted: Line spacing: 1.5 lines

Amino Acid Titration Assay
Amino acid titration assays were done by supplementing growth media with
various concentrations of indicated amino acids as listed in figures and figure legends.
Cells were analyzed as described for β-galactosidase activity assays.
EMS Mutagenesis
Yeast cells (ZLY043) were grown overnight at 30°C in 10 mL YPD liquid media to
saturation. 1 mL of the saturated culture was pelleted and subjected to EMS
mutagenesis as described in Methods Enzymology [52]. After EMS mutagenesis,
cysteine resistant colonies were selected for on SD + 5 mM cysteine plate media.
Cysteine resistant cells were subject to confirmation by β-galactosidase assays as
described above.
9

Mating
MATa and MATα haploid yeast cells were cross streaked and mated on YPD
plate media for 4 hrs. Diploids were selected for on SD plate media supplemented with
amino acids to cover auxotrophic markers.

Results
The Effects of 20 Common L-amino Acids on AGP1-lacZ Expression
Formatted: Indent: First line: 0.5"

It has been shown previously that, with the exception of proline, the presence of
a single amino acid in the growth medium induces the expression of the lacZ gene
under the control of the promoter of high-Affinity Glutamine Permease 1 (AGP1), a
target gene of SPS signaling. Leucine and tryptophan were found to be strong inducers
of expression of the AGP1-lacZ reporter. Ssy1-dependent AGP1-lacZ expression can also
be triggered by nitrogenous compounds other than common amino acids, such as
citrulline, GABA, and ornithine [14]. However previous experiments were carried out
using a fixed amino acid concentration. In my study, systematic amino acid titration
assays were performed in order to obtain information on the affinity and potency of
individual amino acids on Ssy1.
First, I performed amino acid titration assays of 20 L-amino acids individually at
eight different concentrations from 0 to 1.6 mM on the activity of an AGP1-lacZ reporter.
RBY98661 strain yeast cells containing an integrated AGP1-lacZ reporter gene were
grown in minimal SD medium overnight in the presence of different concentrations of
individual amino acids. Cells were collected at OD600 0.6-0.8 and β-galactosidase assays
were performed to measure the activity of the AGP1-lacZ reporter gene as described in
Material and Method.
10

Overall, the results showed that AGP1-lacZ expression was induced to various
levels by 19 L-amino acids, except proline (Fig. 3). This suggests that the Ssy1 sensor has
a broad substrate binding specificity; furthermore, Figure 3 shows that expression of
AGP1-lacZ gradually increases in cells grown in the presence of increasing amounts of
amino acids until reaching a maximum, and its activity slowly decreases.
Figure 4 represents a single response curve selected from figure 3. It shows a
typical response of AGP1-lacZ expression in cells grown in SD medium supplemented
with titrating amounts of an amino acid, in the case of phenylalanine. AGP1 expression
starts at zero in the absence of phenylalanine in the growth medium, then peaks, then
gradually decreases with increasing amounts of phenylalanine. The (x, y) coordinate of
the peak point provides two important parameters: the value on the X-axis provides
information on the affinity and the value on the Y axis on the potency of phenylalanine
on Ssy1. The concentration of amino acid that gives the maximum AGP1-lacZ
expression provides information on how tightly it binds to Ssy1: the lower the
concentration of that amino acid when reaches its maximal activity, the higher the
affinity of the Ssy1 sensor toward that amino acid. The peak value on the Y axis reveals
the potency of this amino acid in activating Ssy1: the higher the value on the Y axis of
the peak point, the more potent that amino acid in activating Ssy1.
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Figure 3: AGP1-lacZ expression in response to titrating levels of 20 L-amino acids
individually. AGP1-lacZ expression was determined in RBY98661 strain grown in
minimal SD medium with titrating concentrations (0-1.6 mM) of 20 different L-amino
acids individually using β-galactosidase assays.
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Figure 4: The AGP1-lacZ expression curve in response to increasing levels of
phenylalanine provides information of its activity and potency on Ssy1. βgalactosidase assays of AGP1-lacZ expression were conducted for RBY98661 strain cells
grown in minimal SD medium with titrating concentrations (0~1.6 mM) of
phenylalanine. The interception of maximal AGP1 expression at the X- axis reveals the
affinity of Ssy1 for phenylalanine. The interception of maximal AGP1 expression at the
Y-axis shows the potency of phenylalanine in activating Ssy1.

Amino Acids with Aromatic R Groups Have High Affinity for Ssy1 and High Potency
in Activating AGP1-lacZ Expression
Based on the response curve of AGP1-lacZ expression in the presence of titrating
levels of individual amino acids, Ssy1 has various binding affinities towards different
amino acids (Figure 3). The potency of different amino acids, represented by the
13

maximum activation of AGP1-lacZ expression in the presence of amino acids, vary as
well. Therefore, I grouped amino acids based on the physio-biochemical property of
their R groups and looked separately at the binding affinity and the potency of the Ssy1
sensor to these amino acids.
Among the 20 L-amino acids, phenylalanine, tryptophan, and tyrosine possess
an aromatic R group. AGP1-lacZ expression in the presence of very low amounts of
these three amino acids (between 25 µΜ to 100 µΜ) was highly induced (between 900 to
1100 nmoles/min/mg protein) (Fig. 5) suggesting the Ssy1 amino acid sensor has a high
binding affinity for amino acids with aromatic R groups and these amino acids have a
high potency for activating Ssy1.
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Figure 5. AGP1-lacZ expression in response to stimulation with amino acids with
aromatic R groups.
β-galactosidase activity assays on AGP1-lacZ expression were conducted for RBY98661
strain cells grown in minimal SD medium with titrating concentrations (0-1.6 mM) of
tyrosine, tryptophan, and phenylalanine.
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Amino Acids with Hydrophobic R Groups Have Medium Affinity and medium potency
on Ssy1
Alanine, isoleucine, leucine, methionine, valine, and proline contain hydrophobic
R groups. With the exception of proline, both the binding affinity of Ssy1 towards this
group of amino acids and the potency of these amino acids in activating fall into the
middle range (Fig.6). The AGP1-lacZ reporter gene is activated in cells by these amino
acids at concentrations between 100 µΜ to 400 µΜ, and AGP1-lacZ expression is
15

induced to a level between 400 to ~700 nmoles/min/mg proteins. Consistent with
previous studies, proline did not activate expression of the AGP1-lacZ reporter gene [4].
This may be due to the distinctive, rigid cyclic structure of proline’s side chain.

Figure 6: AGP1-lacZ expression in response to stimulation with amino acids with
hydrophobic R groups
β-galactosidase activity assays on AGP1-lacZ expression was conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-1.6 mM) of
isoleucine, leucine, valine, alanine, methionine, and proline.
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Amino Acids with Uncharged Hydrophilic R Groups Have Medium to Low Affinity and
Potency on Ssy1
Glutamine, asparagine, cysteine, serine, threonine, and glycine contain
uncharged hydrophilic R groups. AGP1-lacZ expression is only fully activated by
relatively high concentrations of these amino acids (>200 µΜ) and AGP1-lacZ expression
reaches maximum between 250 to 700 nmoles/min/mg proteins (Fig. 7). These data
suggest that amino acids with uncharged hydrophilic R groups have medium to low
binding affinity on Ssy1, and medium to low potency in activating Ssy1. Interestingly,
expression of AGP1-lacZ did not reach its peak in the presence of 1.6 mM cysteine or
glycine, the highest concentration tested in our assays. Threonine had a higher affinity
and potency on Ssy1 as compared to other amino acids of this group, which is similar to
amino acids with non-aromatic hydrophobic R groups. This may be due to the presence
of a methyl group on the side chain of threonine.
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Figure 7: AGP1-lacZ expression in response to stimulation with amino acids with
uncharged hydrophilic R groups
β-galactosidase activity assays on AGP1-lacZexpression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-1.6 mM) of
threonine, asparagine, cysteine, glutamine, serine, and glycine.

Effect of Amino Acids with Charged R Groups on AGP1-lacZ Expression
Arginine, histidine and lysine contain positively charged R groups, while
glutamic acid and aspartic acid contain negatively charged R groups. Figure 8 shows
that in the presence of 400 µΜ glutamic acid, AGP1-lacZ expression reached a maximum
of 600 nmoles/min/mg proteins; and in the presence of 800 µΜ aspartic acid, AGP1-lacZ
expression reached a maximum of 350 nmoles/min/mg protein. Compared to the
negatively charged amino acids, cells grown in the presence of positively charged
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amino acids did not fully activate AGP1-lacZ expression at the highest concentration 1.6
mM, suggesting that the binding affinity of Ssy1 for positively charged amino acids is
extremely low.

Figure 8: AGP1-lacZ expression in response to stimulation with amino acids with
charged R groups
β-galactosidase activity assays of AGP1-lacZ expression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-1.6 mM) of glutamic
acid, aspartic acid, arginine, histidine, and lysine.
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The Effect of Very High Concentrations of Glycine, Histidine, Arginine and Lysine on
AGP1-lacZ Expression
Out of twenty L-amino acids, glycine, histidine, lysine, arginine, and cysteine did
not lead to maximum induction of AGP1-lacZ expression at a concentration of 1.6 mM.
Hence, further titration assays were performed on these amino acids to examine their
effect on AGP1-lacZ expression at very high concentrations, up to 12.8 mM.
Remarkably, Figure 9 shows that AGP1-lacZ expression is highly induced by 12.8 mM
glycine or histidine, but the induction still did not reach its maximum. AGP1-lacZ
expression appears to be fully induced in cells grown in the presence of 400 µM
arginine, and it plateaus in the presence of higher amounts of arginine. In the case of
lysine, AGP1-lacZ expression appears to reach maximum at 6.4 mM lysine (Figure 9).
Based on the generation time of cells grown in the presence of 1.6 mM individual amino
acids, cysteine is the most toxic. In the presence of 1.6 mM cysteine, yeast cells have
severe growth defects. Therefore, no further analysis was done on cysteine beyond 1.6
mM concentration.
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Figure 9: AGP1-lacZ expression in response to stimulation with very high levels of
glycine, histidine, lysine, and arginine.
β-galactosidase activity assays on AGP1-lacZ expression were conducted on RBY98661
cells grown in minimal SD medium with titrating concentrations (0-12.8 mM) of glycine,
histidine, lysine, and arginine.
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Position of Alanine’s R-Group is Critical for Sensing via Ssy1
Each common amino acid has four substituents around the Cα carbon: the R
group, the carboxyl group, the amino group, and the hydrogen atom. To determine
whether the position of the R-group around the Cα carbon affects sensing by Ssy1, I
compared AGP1-lacZ expression in cells grown in the presence of L-alanine versus βalanine, in which the amino group linked to the Cβ carbon. Figure 10 shows that βalanine only weakly activates AGP-lacZ expression, suggesting that the position of the R
group of common amino acids is important for amino acid sensing by Ssy1.

Figure 10: AGP1-lacZ expression is affected by the position of alanine’s R-group
β-galactosidase activity assays on AGP1-lacZ expression were conducted for
RBY98661 cells grown in minimal SD medium with titrating concentrations (0-1.6 mM)
of L-alanine versus β-alanine.
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The Hydrogen Atom Linked to the Cα Carbon is Critical for Sensing via Ssy1
Next we examined whether the hydrogen atom attached to the Cα carbon is
important for amino acid sensing by Ssy1. We performed amino acid titration assays on
AGP1-lacZ expression using L-phenylalanine and L-α-methyl-phenylalanine, in which
the hydrogen atom is replaced with a methyl group at the Cα carbon. Figure 11 shows
that AGP1-lacZ expression is highly induced in the presence 50 µΜ phenylalanine, but
L-α-methyl-phenylalanine has no effect on AGP1-lacZ expression even at 0.8 mM
concentration, suggesting that the hydrogen atom around the Cα carbon of amino acids
is critical for amino acid binding to and/or activation of Ssy1.

Figure 11: AGP1-lacZ expression induced by L-phenylalanine is abolished by the
substitution of the hydrogen atom linked to the Cα carbon with a methyl group.
Formatted: Line spacing: 1.5 lines

β-galactosidase activity assays of AGP1-lacZ expression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-900 µM) of L-αmethyl-phenylalanine versus L-phenylalanine .
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D-Amino Acids Have Variable Effects on Ssy1 Activation
L-amino acids are the building blocks of proteins, metabolic fuels for cells, and
precursors for biosynthesis [53]. D-amino acids are not as common, but they can be
found in bacterial cell walls, in antibiotics produced in bacteria and fungi, and in small
peptides found in both vertebrates and invertebrates [54, 55]. Since Ssy1 has a broad
binding specificity for L-amino acids and other nitrogen compounds[14], I wondered
whether a change in the entire configuration of an amino acid around the Cα carbon
affects Ssy1 sensing. To test this, I compared the effects of 14 pairs of D- and L-amino
acids on AGP1-lacZ expression using β-galactosidase activity assays. The results
showed that the D-isoforms of L-amino acids have variable effects on Ssy1 activation.
Based on relative ability of D-amino acids in activating Ssy1 as compared to their Lamino acid counterparts, I divided these 14 pairs of L- and D-amino acids into three
groups.
Group 1, including leucine and aspartic acid, showed that the D-isoform
appeared to have the same affinity but higher potency for activating Ssy1 as compared
to its L-isoform counterpart (Figure 12).
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Figure 12: The D- isoforms of Group 1 amino acids have the same affinity and higher
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potency on Ssy1 activation.
β-galactosidase activity assays of AGP1-lacZ expression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations of (A) D- and Lleucine and (B) D-and L-aspartic acid.
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Group 2 amino acids, including alanine, phenylalanine, serine, tyrosine,
asparagine, methionine, and arginine showed that the D-isoforms had much lower
affinity yet similar or greater potency on Ssy1 as compared to their L-isoform
counterparts (Fig. 13). Interestingly, although L-arginine is a weaker activator of Ssy1
(Fig. 9), D-arginine induced AGP1-lacZ expression to a level similar to that achieved by
the most potent L-aromatic amino acids. Group 3 amino acids, lysine, glutamic acid,
glutamine, valine, and proline, the D-isoforms had little or no activity on Ssy1.
Formatted: No Spacing, Indent:
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Figure 13: The D- isoforms of Group 2 amino acids have lower affinity but similar or
higher potency for Ssy1.
β-galactosidase activity assays of AGP1-lacZ expression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-12.8 mM) of the D-
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and L-isoforms of (A) serine, (B) tyrosine, (C) alanine, (D) phenylalanine, (E)
methionine, (F) arginine, or (G) asparagine.

A

B

C

D

E

Figure 14: The D- isoforms of Group 3 amino acids had little or no activity in
activating Ssy1.
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β-galactosidase activity assays of AGP1-lacZ expression were conducted for RBY98661
cells grown in minimal SD medium with titrating concentrations (0-12.8 mM) of the Dor L-isoforms of (A) glutamine, (B) glutamic acid, (C) lysine, (D) valine, or (E) proline.
Cysteine Toxicity
As I mentioned previously, excess amounts of amino acids inhibit yeast cell
growth. Cells started to die in response to increased amounts of amino acids present in
the growth medium (data not shown). Among the twenty essential L-amino acids I
assayed, cysteine appeared to be the most toxic to the cells. It took 48 hours to grow 6
generations of yeast cells in 1.6 mM cysteine while the wild type cells took less than 24
hours to grow 6 generations. Growth of yeast cells was not observed at cysteine
concentrations beyond 1.6 mM. Hence I questioned why is cysteine, among all other
amino acids, the most toxic? Also, how does cysteine cause growth deficiency in cells?
To answer these questions it was necessary to isolate cysteine resistant mutants.
Cysteine is part of the methionine biosynthesis superpathway; it can be
produced from methionine degradation (Fig 15). I suspected that cells grown in high
concentration of cysteine results in accumulation of intracellular cysteine, the end
product of methionine degradation, which triggers negative feedback that inhibits
breakdown or usage of methionine in the cell. To that end, I grew PLY126K1 cells in the
presence of 1.6 mM cysteine, and in the presence of 0.2 mM methionine or/and 0.2 mM
threonine respectively. By comparing the growth of cells in the absence or presence of
cysteine, the additional methionine or threonine did not improve the growth defect of
cells in the presence of cysteine (data not shown). The result suggests that cysteine
toxicity in cells may not due to inhibition of methionine degradation, but may inhibit
other pathways which cysteine is involved in.
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Figure 15: Methionine metabolic pathway
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Isolation Cysteine Resistant Mutants
Since the presence of cysteine activates AGP1-lacZ expression through the SPS
amino acid signaling pathway [4], I first sought to determine whether mutations to
SSY1, PTR3, or SSY5, which block the SPS signaling pathway and uptake of cysteine,
could confer resistance to cysteine toxicity. To that end, I tested the growth of ssy1∆,
ptr3∆, ssy5∆ strains generated previously in Liu’s lab and the WT cells on SD versus SD
+ 5mM cysteine plates. Figure 16 shows that the deletion of SSY1, PTR3, or SSY5 can
confer resistance to cysteine toxicity, indicating that toxicity of cysteine involves, at the
very least, sensing it in the extracellular environment.

30

Figure 16: ssy1∆, ptr3∆, and ssy5∆ mutations confer resistance to cysteine toxicity.
WT, ssy1∆, ptr3∆, and ssy5∆ strains were grown on SD plates without or with 5 mM
cysteine. WT strains were not able to grow on medium contain high concentration of
cysteine, but ssy1∆, ptr3∆, and ssy5∆ strains showed resistance to cysteine toxicity.

The discovery that deleting SSY1, PTR3, or SSY5 confers resistance to cysteine
toxicity is not surprising since the SPS amino acid sensing pathway requires these
proteins to sense and respond to extracellular amino acid [2]. This information however,
does not provide enough information to answer the question of how or why cysteine is
toxic to cells. To that end I conducted a genetic screen to identify mutations that can
confer resistance to high concentrations of cysteine other than mutations in Ssy1, Ptr3,
and Ssy5. In order to do that, I transformed PLY126K1 cells, integrated with the AGP1lacZ reporter gene, with plasmids pRS416-STP1p-STP1C and pRS417-GPD1-STP1myc3-2. It has been shown that overexpressing STP1 activation domain leads to
constitutive activation of transcription in SPS signaling pathway, meaning
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transformants could bypass Ssy1, Ptr3, and Ssy5 to constitutively express AGP1-lacZ
reporter gene [6]. I intentionally increased the WT cell’s ability to uptake extracellular
cysteine, which would theoretically prevent isolation of mutation in Ssy1, Ptr3 and
Ssy5. Then the transformants were mutagenized with ethyl methanesulfonate (EMS),
which produces mutations in the DNA via guanine alkylation which generates random
G-C nucleotide substitution [52]. EMS treated cells were diluted and plated directly on
solid SD + 5 mM cysteine plate. Single colonies that were resistant to cysteine toxicity
were isolated and assayed on solid SD versus SD + 5 mM cysteine plates for their ability
to grow normally compared to the growth deficiency of the WT cells (Table 1). 10
colonies were further confirmed to be cysteine resistant.
These 10 colonies were grown in SD + 0.02% leucine to activate SPS amino acid
sensing and analyzed via β-galactosidase activity assays, which allowed me to
phenotypically analyze different mutations. Figure 17 shows that of the 10 cysteine
resistant mutants, 7 showed no AGP1-lacZ reporter gene activity. This observation
indicates that these 7 mutations were due to mutation in the SPS signaling pathway
leading to defects in activation of AGP1 reporter gene, even though I had intentionally
minimized the possibility of isolating SPS pathway defect mutations.
Mutants 1 and 2 expressed the AGP1-lacZ reporter gene to a similar level to WT
cells, and mutant 10 had a 0.5 fold increase in AGP1-lacZ activity than WT cells. Because
these three mutants have expression of the AGP1-lacZ gene, amino acids appears to be
transported into yeast cells normally in these mutants; hence, this observation suggests
that cysteine resistance in these three mutants are not due to deficiency in uptake of
extracellular cysteine caused by mutation in SPS signaling pathway, but may be due to
the intracellular processing of cysteine.
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Table 1. Mutants generated from EMS mutagenesis are resistant to high levels of
cysteine. Wild type and mutant strains were streaked onto SD plates with or without 5
mM cysteine and incubated at 30 C for 3-4 days.
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Identification of Cysteine Resistant Mutants
As shown previously, cysteine resistance can be caused by mutations in
components involved in the SPS amino acid signaling pathway. These mutations likely
block extracellular cysteine uptake into yeast cells. Even though I tried to generate
mutants that bypass SSY1, PTR3, and SSY5, β−galatosidase results in Figure 17 showed
some mutants were defective in expressing AGP1-lacZ reporter gene. To identify the
mutations responsible for cysteine resistance, especially the ones which were defective
in SPS signaling pathway, I first sought to identify whether some of the cysteine
resistant colonies were still due to mutations in SSY1, PTR3, or SSY5. To that end, I first
streaked mutants on YPD plate to lose their plasmids, then transformed MATa WT and
the 10 cysteine resistant mutants with pRS416 empty vector containing the URA3
marker. I also transformed MATα WT, ssy1∆, ptr3∆ ssy5∆, ssy5∆, dal81∆, and shr3∆
strains containing the AGP1-lacZ reporter gene, which all are essential components in
activating the SPS amino acid signaling pathway, with the pRS417 empty vector
containing the LYS2 marker for selection purposes. I mated MATa transformants to the
MATα deletion strains and then assayed the expression of AGP1-lacZ in the resulting
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diploids. Of the 10 mutants, mutant 1 failed to mate indicating that mutant 1 may have
a mutation in a gene involved in the mating process. Diploid cells from the remaining 9
mutant groups were grown in SD media + 0.02% leucine to activate SPS amino acid
sensing and assayed individually via β-galatosidase assays. Figure 18A shows that
diploids resulting from mating with WT cells showed activation of AGP1-lacZ
expression indicating mutations leading to cysteine resistance are recessive. When
cysteine mutants mated with ssy1∆ strain, AGP1-lacZ activities of mutants 5, 11, 13, 14,
and 16 were completely abolished, indicating that these mutants are resistant to
cysteine due to the mutation in the gene encoding the Ssy1 sensor (Fig.18 B). Similarly,
AGP1-lacZ activity was abolished in diploids from mutant 6 mated with ssy5∆ cells
indicated that mutant 6 is resistant to cysteine because of a mutation in the gene
encoding the Ssy5 protease (Fig.18 D).
Mutant 8 mated to the double ptr3∆ ssy5∆ double mutant had no AGP1-lacZ
activity (Fig. 18C); yet, mating mutant 8 with the single ssy5∆ mutant had AGP1-lacZ
expression similar to WT (Fig. 18D). This suggests that mutant 8’s cysteine resistance is
likely due to a mutation in the gene encoding the Ptr3 protease.
Diploids resulting from mutants 4 and 10 showed varying AGP1-lacZ activities
compared to WT and none showed abolishment of AGP1-lacZ activity (Fig.18)
indicating that these mutations are in ssy1∆, ptr3∆ ssy5∆, ssy5∆, dal81∆, or shr3∆.
Specific mutated sites of mutant 4 and 10 are still unknown.
Overall, seven mutants which abolished AGP1-lacZ activity were found to be due
to mutations in components that lead to malfunctions of the Ssy1-Ptr3-Ssy5 amino acid
signaling pathway. This observation confirms that defective SPS amino acid signaling
pathway can block uptake of extracellular cysteine and result in cell resistance of
cysteine toxicity.
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Figure 17: AGP1-lacZ gene expression in 10 cysteine resistant mutants
Cultures of 10 cysteine resistant mutant cells grown in SD medium + 1.5mM leucine
were assayed for AGP1-lacZ activity via β-galactosidase assay. 7 out of 10 mutant
cysteine resistant strains are due to SPS signaling pathway defects, but the 3 mutations
are not.
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Figure 18: Identification of cysteine resistant mutants
AGP1-lacZ activity in diploids of 9 haploids mutated cells mated to (A) WT cells, (B)
ssy1∆ mutant cells, (C) ptr3∆ ssy5∆ double mutant cells, (D) ssy5∆ mutant cells, (E)
dal81∆ mutant cells, and (F) shr3∆ mutant cells. Diploid cells were grown in SD media +
0.02% leucine and assayed via β-galactosidase assay.
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Mutant 8 is Resistant to Cysteine Because of a Mutation in PTR3
Mutant 8’s cysteine resistance is likely due to a mutation in the gene encoding the Ptr3
protease. (Fig. 18 C and D). To confirm this, I transformed wildtype PTR3 encoded on a
centromeric plasmid into mutant 8. If mutant 8 is due to a ptr3∆ mutation, the WT copy
of PTR3 gene transformed in plasmid will complement its mutation and restore AGP1lacZ activity. Figure 19 shows that a WT copy of PTR3 complements the mutation of
mutant 8 and restores AGP1-lacZ confirming that mutant 8 is resistant to cysteine
toxicity because of a mutation in PTR3.

Figure 19: Mutant 8 contains a mutation in PTR3

β-galactosidase assay of AGP1-lacZ expression in WT, mutant 8, and mutant 8
transformed with Ptr3 plasmid grown in SD media + 0.02% leucine respectively were
analyzed.
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Discussion
In this study, I show that the Ssy1 sensor has different binding affinity and
sensitivity to 20 common L-isoform amino acids, with the exception of proline. Also,
positioning of the R group and hydrogen atom around the alpha carbon of amino acids
is crucial to amino acid sensing. Remarkably, the Ssy1 sensor can also sense D-amino
acids to various degrees. The fact that the Ssy1 sensor can detect the most common
amino acids in both L- and D- isoforms suggest that the Ssy1 sensor binding pocket is
likely very large and flexible. The Ssy1 sensor shows strongest affinity and sensitivity to
amino acids with aromatic groups followed by those with hydrophobic groups, next to
those with neutral hydrophilic group, then to negative charged group, and lastly has
the lowest affinity and sensitivity to positively charged amino acids. Based on this
observation, the Ssy1 sensor more likely contains more hydrophobic amino acids
residues, and more negatively charged amino acid residues in its binding pocket that
may play an important role in its sensing activity.
Among 20 common amino acids, L-cysteine is an amino acid containing a thiol
group that is nucleophilic and easily oxidized. Cysteine is the precursor of the
antioxidant glutathione whose thiol group of cysteine undergoes redox reactions and
forms a peptide linkage to carboxyl group of the glutamate side chain [56, 57].
Oxidation of the cysteine thiol group generates a disulfide bond, playing an important
role in the folding and stability of some proteins. It is also a very important precursor of
iron-sulfur cluster proteins, which play important roles in oxidation-reduction reaction
in mitochondria electron transport.
Like any other living organism, cysteine is essential for cellular metabolism in
yeast. In S. cerevisiae, cysteine can be synthesized from methionine or be taken up from
the surroundings. However, high concentrations of cysteine are the most toxic amino
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acid to cells. Its cysteine toxicity was examined in yeast cells grown in minimal medium
with up to 5 mM cysteine, and cysteine inhibits growth of yeast in a dose-dependent
manner [58]. It has been shown that all 7 permeases targeted by the SPS signaling
pathway (Bap2, Bap3, Agp1, Gnp1, Tat1, Tat2, and Mup1) are able to uptake
extracellular cysteine in either non-repressing nitrogen source or ammonium-based
source [19, 59, 60]. High level of expression of cysteine uptake permeases possibly
explains why cysteine at high concentration is the most toxic to yeast cells compared to
other amino acids. My results show that mutations in the SPS signaling pathway lead to
resistance to cysteine toxicity in cells, likely because these mutations inhibit expression
of cysteine transporter genes and block cysteine uptake from the environment.
Interestingly, three cysteine resistant mutants were still able to express the AGP1-lacZ
reporter gene; therefore, cysteine appears to be transported normally into these
mutants. This observation suggests that cysteine resistance in these three mutants may
be due to either mutation in an unknown signaling pathway expressing permeases that
also transport cysteine into the cells, or, more likely, the intracellular processing of
cysteine.
The intracellular mechanism that causes cysteine cytotoxicity in yeast has not
been well studied; therefore, it is difficult to speculate why these three mutants are
cysteine resistant. One possible explanation of intracellular cysteine resistance could be
due to mutations in methionine-cysteine biosynthesis. Many enzymes involved in
nitrogen anabolism are inhibited and their synthesis is repressed upon accumulation of
the end or intermediate products of biosynthetic pathways [61]. Homocysteine is the
intermediate in the ubiquitous methionine cycle to synthesize cysteine, and it is
essential to generate one-carbon methyl groups for transmethylation reactions [62].
Cysteine toxicity effects studied in human shown that elevated level of homocysteine
increases the risk of having cardiovascular diseases [63] and associates with other
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diseases. A high level of cysteine shows similar toxic effects. Changes in plasma
cysteine correlates with changes in BMI, cholesterol, and diastolic blood pressure [64].
As predicted, total plasma cysteine is also a risk factor for vascular diseases, and
concentrations of cysteine present in plasma show a U-shape correlation with
peripheral and cerebrovascular disease [65]. S. cerevisiae, which shares a considerable
similarity with higher eukaryotic cellular organization and function, has been used as a
model to study the impacts of elevated level of homocysteine and cysteine on cellular
physiology and pathology. Kumar and his colleagues observed that additional thiols
from homocysteine or cysteine down-regulated genes coding for antioxidant enzyme,
but upregulated genes responsible for ER stress and glycolysis pathway. They
concluded that cytotoxicity is probably due to ER stress [58]. It is very likely that
cysteine resistance observed in mutants that could still express AGP1 may be due to
mutations in genes involved in a methionine signaling pathway (Fig.19), which allows
bypass of detection and signaling of excess thiol groups in cells.
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CHAPTER 3: HAP4 EXPRESSION IS REGULATED BY THE
MEDIATOR COMPLEX
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Introduction
CCAAT-binding proteins (CBPs) are transcription activators that promote
expression of protein-coding genes by interacting with CCAAT consensus sequence
motifs within promoters [22]. Under fermentative conditions (in the presence of
glucose), the CBP of yeast, termed the Hap2/Hap3/Hap4/Hap5 complex, binds to
CCAAT-box containing upstream activation sites (UASs) to initiate gene responses to
metabolize non-fermentable carbon sources (galactose/raffinose) [23-28]. Hap2, Hap3,
and Hap5 form a heterotrimer which is required for CCAAT DNA binding at the
promoter region [24], however activation of transcription can only be triggered when
the Hap4 completes the complex [26]. The regulatory subunit, Hap4, is known to be
transcriptionally controlled by carbon sources, and contains the activation domain of
the complex[29]. Increased Hap4 levels results in switching from fermentation to
respiration in yeast, termed the diauxic shift. However, regulation of HAP4 expression
has been poorly studied. Previously the Liu Lab observed SIN4, a component of the
mediator tail region, and CYC8, a general transcription co-repressor with TUP1, showed
as negative regulators of HAP4 expression. This prompted me to study the mechanism
underlying HAP4 regulation by the Mediator complex.
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Materials and Methods
Strains, Primers, Plasmids, Growth Media and Growth Conditions
Yeast strains, primers, and plasmids used in this study are listed in Table 1, Table
2, and Table 3, respectively. Yeast cells were grown at 30 °C in SD medium (0.67% yeast
nitrogen base and 2% D-glucose), S5%D medium (0.67% yeast nitrogen base and 5% Dglucose), SR (0.67% yeast nitrogen base and 2% raffinose), YNBcasD (0.67% yeast
nitrogen base, 1% casamino acids, and 2% D-glucose), YNBcas5%D (0.67% yeast
nitrogen base, 1% casamino acids, and 5% D-glucose), YNBcasRaff (0.67% yeast
nitrogen base, 1% casamino acids, and 2% raffinose), and YPD (2% peptone, 1% Bactoyeast extract, and 2% D-glucose). The amino acids L-leucine, L-lysine, L-histidine, Lmethionine, L-tryptophan, and/or uracil were added to growth media to a final
concentration of 30 mg/L to meet auxotrophic requirements [50]. Solid media contained
2% agar in addition to the components described above when needed. MG132 (50 µM)
was added to the growth media to inhibit proteasome activity [66] for experiments
testing proteasome dependent protein degradation.
Yeast Transformations and β-galactosidase Activity Assays
Yeast cells were transformed [51]. Transformants carrying the desired plasmids
were selected on YNBcasD plates. Liquid cultures were inoculated with a pool of
several independent transformants and grown overnight in YNBcas5%D or into
YNBcasR medium to an optical density at 600 nm of ~0.6. In glutamate repression
analysis, liquid S5%D and SR media were used. The cell extracts were prepared by
using glass bead lysis method. 10 – 90 mL of clear cell extract of independent samples
were objected to β-galactosidase assays, hydrolyzing o-nitrophenyl-β-dgalactopyranoside (ONPG) [50]. Protein concentration of individual sample was carried
out by performing Bradford assay, using bovine serum albumin as the standard.
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Reporter lacZ activity was calculated in nmoles of hydrolyzed ONPG per minute per
mg of protein. For each plasmid-strain combination, assays were conducted in duplicate
and independent experiments were carried out two to three times.
Cellular Extract Preparation and Immunoblotting
Total cellular protein extracts were prepared by lysing yeast cells in extraction
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buffer (1.85 N NaOH – 7.5% β-mercaptoethanol) followed by precipitation with
trichloroacetic acid (TCA) [67]. TCA was neutralized and total cellular proteins were
structurally linearized in 1M un-buffered Tris, 1M dithiothreitol, and 1X SDS-PAGE
loading buffer followed by heat treatment. Proteins were separated by SDS-PAGE gel,
and transfer onto nitrocellulose membrane via Western blotting.
myc- and HA- tagged proteins were probed with anti-myc primary antibody and
anti-HA primary antibody (3F10, Roche), respectively. Primary antibodies were
detected by HRP conjugated goat anti-mouse secondary antibody and HRP conjugated
goat anti-rat secondary antibody, respectively. Chemiluminescence was induced by an ECL
reagent. Chemiluminescence images of Western blots were captured using the Bio-Rad
Chemi-Doc photo documentation system. (Bio-Rad Laboratories, inc., Hercules, CA).
For loading control visualization, blots were deprobed in stripping buffer (2%SDS0.08% β-mercaptoethanol) for 45 min at 60 °C with shaking, and then be reprobed with
anti-PGK1 (3-phosphoglycerate kinase) primary antibody, followed by HRP conjugated
goat anti-rabbit secondary antibody. Chemiluminescence was induced by an ECL reagent.
Images of reprobed blots were captured using the Bio-Rad Chemi-Doc photo
documentation system.
Library Complementation of a HAP4 Expression Activating Mutation
One highly activating HAP4 expression mutant (DCY125-13) was transformed
with myc-tagged LEU2 CEN mediator plasmids, which were constructed in this study.
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Transformants were selected for on SD plate media supplemented with histidine and
methionine (SD+HM). After 2-3 days, pools of colonies from each transformation were
grown in 10mL SD+HM liquid media. Potential candidates containing a complementing
plasmid were selected by their growth on plates and further phenotype confirmation
via β-galatosidase assay.
Cycloheximide Chase Assay
Cells expressing indicated myc-tagged proteins were grown in liquid S5%D+HM
or SR+HM medium to OD600 0.6 – 0.8. Protein synthesis was inhibited by addition of 50
µg/mL cycloheximide. Every 30 minutes, a 1 mL sample of the cell culture was
withdrawn and immediately subjected to TCA precipitation. Total cellular extracts were
prepared, and myc-tagged protein levels were determined by probing Western blots as
described above. Loading controls were obtained by stripping the membrane and
reprobed with anti-PGK1 (3-phosphoglycerate kinase) primary antibody.
Determination of Srb8 Half-life
Erg6Δ mutant cells, expressing HA-tagged Srb8 were treated with 50 mM and
100 mM MG132 and no treatment, and grown in liquid YNBcas5%D or YNBcasRaff
medium. Once cells reached OD600 between 0.6 and 0.8 they were subjected to
cycloheximide chase assay. Srb8-HA protein levels were detected by Western blot, and
Srb8 protein half-life was estimated from observation of different protein levels
expressed in every 30 minutes.
Mating and Tetrad Dissection
MAT a and MAT α haploid yeast cells were mated on YPD plate media for 4 hrs.
Diploids were selected for on SD plate media supplemented with amino acids to cover
auxotrophic markers. Diploids were induced to undergo sporulation by growing in
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sporulation media (1% potassium acetate, 0.1% Bacto-yeast extract, 0.05% raffinose) for
6-10 days. Tetrads were dissected on YPD plates using a micromanipulator.

Results
Hap4 Expression is Regulated by the Mediator Complex
HAP4 expression increases approximately ten-fold when yeast cells are grown in
raffinose media compared to dextrose media. Despite the importance of mitochondria
in cellular metabolism and the essential role of hap4 in mitochondrial biogenesis, the
regulatory mechanism of HAP4 expression is still unclear. The mediator complex of
yeast has been shown in Liu’s lab to be involved in negative regulation of HAP4
expression. Recently, Med8, another component of the Mediator complex, has been
implicated in the carbon catabolite repression pathway [68]. Therefore, I sought to
characterize the role of each component of the Mediator complex in Hap4 regulation.
HAP4 expression was analyzed in cells lacking 15 non-essential mediator
components. These mutant strains, transformed with plasmid carrying HAP4-lacZ
reporter gene, were already made in the Liu lab. Transformants were grown in S5%D or
SR liquid medium overnight to OD600 0.6-0.8, and assayed for Β−galactosidase activity.
Figure 20 shows that in S5%D grown cells, deletion of mediator components results in
increased of HAP4-lacZ gene expression, up to 10 fold compared to basal HAP4-lacZ
activity in WT cells. However, two of the 14 non-essential mediator complex component
mutations did not increase HAP4-lacZ activity, a med3∆ resulted in HAP4-lacZ activity
comparable to WT and deletion of GAL11 resulted in a 0.5 fold decrease in HAP4-lacZ
activity. In SR liquid medium, deletion of mediator components results in up to a 5 fold
increase in HAP4-lacZ activity. Similar to dextrose grown cells, the exception to this is
that a med19∆ mutation results in HAP4-lacZ activity comparable to WT and gal11∆,
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med3∆, hxk2∆, and med20∆ mutations result in a decrease in HAP4-lacZ activity. These
data suggest that some of the non-essential mediator components negatively regulate
HAP4-lacZ expression while others may positively regulate it.
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Figure 20: The Mediator complex regulates expression of HAP4-lacZ
HAP4-lacZ activity in non-essential mediator component deletion mutants compared to
WT cells. Cells were grown in S5%D medium (A) or SR medium (B) and assayed using
β-galactosidase assays.
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Myc-tagged Mediator Components are Functional
The non-essential mediator components were shown to regulate HAP4-lacZ
expression to various degrees (Fig. 20). It is possible that posttranslational modifications
or protein levels of the mediator complex components may vary depending on growth
conditions and affect HAP4 expression. To test this possibility, I first constructed
centromeric LEU2 plasmids encoding myc-tagged mediator components individually
and tested their functionality (see Table 2).
Centromeric LEU2 plasmids containing non-essential myc-tagged mediator
components were transformed in their corresponding mediator component knockout
strains, containing plasmid of HAP4-lacZ reporter gene, and analyzed for βgalactosidase activity. Figure 21 shows that myc-tagged proteins restored derepressed
Hap4 activity to wild type HAP4-lacZ level; in term, non-essential myc-tagged mediator
component were functional. Non-essential myc-tagged mediator components in their
corresponding mediator component deletion strains complemented the effect a
mediator component deletion mutation has on the expression of HAP4-lacZ.
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Figure 21: Non-essential myc-tagged mediator components are functional.
HAP4-lacZ activities in non-essential mediator component deletion strains without or
with respective myc-tagged mediator component confirm the functionality of nonessential myc-tagged mediator component plasmids. Cells were grown in YNBcas5%D
or S5%D medium and assayed via β-galactosidase assay.

Deletion of essential mediator components is lethal to yeast cells. To examine the
functionality of the constructed essential myc-tagged mediator component plasmids, I
transformed these plasmids into their respective diploid MED/med∆::kanMX4 strain.
Transformants were subjected to sporulation, and yeast tetrads were dissected onto
YPD plates by Tammy Pracheil and tetrad analysis was done by undergraduate
Adrienne McGihn. Tetrads that showed viability of all four spores were selected for
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further analysis on the basis that two spores must contain the wildtype MED gene and
two must have the med∆ with a plasmid based wildtype myc-tagged MED gene.
Viability of all four spores already indicates functionality of the myc-tagged essential
mediator component.
Confirmed essential myc-tagged mediator component plasmids were
transformed into WT cells with the plasmid based HAP4-lacZ reporter gene.
Transformants were then subjected to β-galatosidase assay to examine whether mild
overexpression of essential MED genes from centromeric plasmids affects Hap4
promoter activity. Figure 22 shows that expression of essential myc-tagged mediator
components did not grossly affect HAP4-lacZ gene expression.
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Figure 22: Overexpression of essential myc-tagged mediator components do not
effect HAP4 expression.
HAP4-lacZ activities in essential mediator component deletion strains with respective
myc-tagged mediator components were not significantly affected compared to HAP4
expression in WT cells. Cells were grown in S5%D medium and assayed via βgalactosidase assay.

Carbon Source Affects Myc-Tagged Mediator Components Expression and Processing
It is possible that regulation of HAP4 expression by the mediator complex
involves posttranslational modification or proteolytic processing of mediator
components depending on carbon source availability. To test this, non-essential
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mediator deletion strains with corresponding myc-tagged plasmids and wild type
strains with myc-tagged essential mediator gene used in earlier experiments were
grown in S5%D and SR medium overnight to OD600 0.6-0.8. Cell extracts were prepared
and proteins were separated by SDS-PAGE and visualized by Western-blotting. Figure
23 shows there were seven MED genes that showed a difference in protein expression in
cells grown in dextrose versus raffinose medium. Protein expression of Med4, Med10,
Med20, and Med31 genes were at least twice as strong in dextrose versus raffinose
grown cells. Conversely, protein expression of Gal11 and Srb9 were stronger in
raffinose versus dextrose grown cells.
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Figure 23: Effect of carbon source on Mediator Complex components
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Myc-tagged mediator component protein expressions were detected in dextrose versus
raffinose grown cells.
Interestingly, Srb8-myc was processed into truncated fragments in dextrose
grown cells as compared to raffinose grown cells. One of the possible explanations is
that Srb8 is degraded by ubiquitin dependent proteolytic processing in dextrose grown
cells. To examine this possibility, erg6∆ mutant cells expressing Srb8-myc were grown in
dextrose medium and treated with 50µM and 100µM MG132 (see Material and
Methods). Total cellular proteins with or without treatment of MG132 were
precipitated, separated by SDS-PAGE and Srb8-myc protein was visualized by western
blotting. An erg6∆ mutation increases MG132 permeability [66] . MG132 inhibits
ubiquitin-dependent protein degradation via the proteasome. If Srb8 protein
processing is ubiquitin-dependent, treatment of MG132 should be efficient to block the
degradation of Srb8 protein as I expected to detect a full length Srb8 protein. However,
figure 24 shows no difference in protein expression with or without treatment of MG132
and treatment of MG132 did not inhibit processing of Srb8-myc in dextrose grown cells.
This observation suggested that Srb8 protein processing in dextrose grown cells is not
due to proteasomal degradation.
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Figure 24: Processing of Srb8 in dextrose grown cells is proteasome independent.
Cells expressing in myc-tagged Srb8 were grown in dextrose medium with or without
treatment of MG132 proteasome inhibitor.

Mutant 125-13 is Identified as SRB8 Mutation
Previously, a former member of Liu’s lab, Denise Capps, isolated an unknown
mutant DCY125-13 which fully activates HAP4-lacZ activity in the BY4741 background
dextrose-grown cells. I sought to identify the mutation responsible for the phenotype
observed in mutant. Therefore, I transformed two known negative transcription
regulators, HXK2 or TUP1, or plasmid based myc-tagged mediator components into
DCY125-13 to examine whether these genes could complement the mutation in
DCY125-13. Figure 25 shows that only introduction of SRB8 significantly reduced the
HAP4-lacZ expression in mutant from ~900 nmols/min/mg protein to ~200
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nmols/min/mg protein. This approximately 4 fold reduction of HAP4-lacZ activity
suggested that the DCT125-13 mutant was caused by mutation in Srb8 gene of mediator
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Figure 25: SRB8 mediator component complements HAP4-lacZ activating mutation.
DCY125-13 mutant cells expressing in myc-tagged mediator components were grown in
S5%D medium and assayed via β-galactosidase assay.

56

Formatted: Indent: First line: 0.5"

Since Srb8 is a subunit of kinase module of mediator complex. I wanted to
confirm that DCY125-13 mutant is due to srb8 deletion only. To that end, I mated MATa
srb8∆, srb9∆, srb10∆ and srb11∆ strains containing the plasmid of AGP1-lacZ reporter
gene with MATα 125-13 strain and then assayed the expression of AGP1-lacZ in the
resulting diploids. Figure 26 showed that high HAP4-lacZ activity in 125-13 mutant
was restored to WT cells level by complementing with srb9, srb10, srb11 deletion strain,
but not srb8∆. This observation further confirmed that 125-13 mutant was caused by
mutation in Srb8 gene of mediator complex.

Figure 26: High HAP4-lacZ activity remains in srb8 deletion diploid.
DCY125-13 mutant mated with srb8∆, srb9∆, srb10∆, and srb11 ∆ diploid cells were
grown in YNBcas5%D medium and assayed via β-galactosidase assay
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Effect of Overexpression of Mediator Components on Expression of HAP4
Previously, I showed that the protein levels of Med4, Med10, Med20 and Med31
are stronger in dextrose grown cells as compared to raffinose grown cells; however, no
significant impacts of these genes on HAP4-lacZ activity were observed in earlier
experiments. One explanation for this could be that overexpression of these genes could
affect HAP4 expression. To test this possibility, I cloned these myc-tagged MED genes
into 2 micron plasmids which would greatly induce promoter transcription activity of
these genes. I then transformed the 2 micron plasmids containing these MED genes into
BY4741 WT background cells and confirmed they were overexpressed. Figure 27 shows
that protein expression of the myc-tagged MED genes encoded in 2 micron plasmids
resulted in higher protein levels compared to myc-tagged MED genes encoded in
centromeric plasmids grown in both dextrose and raffinose medium.
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Figure 27: Overexpression of myc-tagged Mediator components.
Protein expression show comparison of centromeric plasmid based myc-tagged
mediator components versus 2µ plasmid based myc-tagged mediator components
grown in dextrose versus raffinose medium.
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Once 2 micron plasmid based myc-tagged MED genes were confirmed to be
overexpressed, I analyzed the effect of their over expression on HAP4-lacZ expression.
Figure 28 shows that overexpression of MED4, MED10, MED20 or MED31 did not
significantly affect HAP4-lacZ activity in dextrose grown cells, but overexpression of
MED4, MED10, MED20 or MED31 did reduce HAP4-lacZ expression in raffinose grown
cells. My previous data showed that Med4, Med10, Med20, and Med31 protein levels
were reduced in raffinose grown cells. Therefore, the data suggests that Med4, Med10,
Med20, and Med31 might play a negative regulatory role in inducing HAP4 promoter
activity since an overexpression of these MED genes correlates with a decrease in
HAP4-lacZ activity in raffinose grown cells, and we can infer that the decrease in
expression of these MED genes seen in raffinose grown cells correlates with an increase
in HAP4-lacZ activity to a level that matches that found in dextrose grown cells.
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Figure 28: Effect of overexpression of myc-tagged Mediator components on HAP4lacZ activity.
HAP4-lacZ activity in cells overexpressing Med4, Med10, Med20 and Med31 were
grown in dextrose (A) versus raffinose (B) medium and were assayed via βgalactosidase assay.
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Overexpression of GAL11 Increases HAP4 Expression
Earlier experiment suggested that Gal11 and Med3 might be positive regulators
of HAP4 expression. In order to test this hypothesis, I transformed plasmids encoded
Gal11-myc and Med3-myc into BY4741 WT cells containing the HAP4-lacZ reporter
gene to see whether additional copies of Gal11 and Med3 would increase HAP4-lacZ
activity. Figure 29 showed that slight overexpression of GAL11 resulted in a 3-fold
increase in HAP4-lacZ activity in dextrose grown cells, and a 0.5-fold increase in HAP4lacZ expression in raffinose grown cells as compared to WT cells. Surprisingly, slight
overexpression of MED3 in WT cells had no effect on HAP4-lacZ activity in cells grown
in both dextrose and raffinose medium.
It is possible that Med3 is a positive regulator of HAP4 expression but to a lesser
extent than Gal11 and thus would require stronger overexpression to see an effect on
HAP4-lacZ activity. To that end, I constructed 2µ plasmids encoding MED3 or GAL11
and transformed them into WT cells containing the HAP4-lacZ reporter gene.
Transformants were subjected to β-galatosidase assays. Figure 29 shows that high
overexpression of GAL11 further increases HAP4-lacZ activity 10-fold as compared to it
is mild overexpression, but high overexpression of MED3 still no significant effect on
HAP4-lacZ activity.
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Figure 29: Effect of overexpression of GAL11 and MED3 on HAP4-lacZ activity
HAP4-lacZ activity in cells overexpressing GAL11 and MED3 on centromeric or 2µ
plasmids grown in dextrose versus raffinose medium.

Med3 and Gal11 Function Together as a Positive Regulator of HAP4 Expression
Neither a MED3 deletion nor overexpression of MED3 affects HAP4-lacZ activity
in WT cells; however, it is possible that Med3 might regulate HAP4-lacZ activity
through Gal11. Therefore, I constructed a gal11∆ med3∆ double deletion mutant strain.
WT, gal11∆, med3∆ single and double deletion mutant cells were transformed with the
HAP4-lacZ reporter gene and grown in YNBcas5%D and YNBcasR media and analyzed
for β-galactosidase activity. Figure 30 shows that a double deletion of GAL11 and MED3
does not completely abolishes HAP4-lacZ reporter gene activity but shows a similar
regulatory effect on HAP4 expression as it is shown in single gal11∆ mutant strain in
figure 20. This observation suggests that the regulatory effect of Med3 is redundant.
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There are other factors that regulate HAP4 expression. By forming a complex with
Gal11, Med3 may positively regulate HAP4 expression in conjunction with Gal11.

Figure 30: HAP4-lacZ activity in med3∆ gal11∆ double mutant
HAP4-lacZ activity of WT, med3∆, gal11∆, and med3∆ gal11∆ double deletion strains
were assayed via β-galatosidase in cells grown in dextrose versus raffinose medium.

Discussion
In this study, I report that the mediator complex components either positively or
negatively regulate HAP4-lacZ activity. Out of 25 mediator components, Med4, Med10,
Med20, and Med31 likely play a negative regulatory role in inducing HAP4 promoter
activity. The kinase, Srb8 is processed in response to glucose medium, and its deletion
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greatly induced HAP4-lacZ activity (Fig. 20, 23). Gal11 appears to be a positive regulator
of HAP4 promoter activity. Sin4 and Hxk2 were previously shown in the Liu lab to
negatively regulate HAP4 promoter activity; my results further suggest that the
mediator complex interacts with a HAP4 transcription factor and each component of
mediator have specific regulatory roles in inducing HAP4 promoter activity. Since the
mediator complex is composed of 25 subunits, they often interact with each other in
regulating transcription; therefore, deletion of one mediator component may have an
effect on neighbor subunits in their regulation of HAP4 promoter activity.
In an early study, it was suggested that Srb10 repressed activation of genes that
enable cells to survive under nutrient deprivation, and that Srb10 expression is greatly
reduced when cells enter diauxic shift [48]. However, changes in SRB10 expression in
nutrient depleted medium was not observed in this study which may due to the
difference in non-glucose sources I used, raffinose compared to galactose they
previously used. Interestingly, I found that another component of kinase complex, Srb8,
underwent processing in cells grown in dextrose. However Srb8 processing is not due
to ubiquitin-dependent degradation and the type of post-translational modification is
still unknown.
Previously, research found that mutation of Srb8 induced invasive growth in
haploid strains [69]. Mutation of Srb8 alleviates repression by Cyc8-Tup1 in vivo. Srb8
can positively regulate the function of Srb10, and balance between the activities of
Srb8+Srb10 and Srb11 is important for normal growth of the cells [70]. Srb8, 9, 10, and
11 tightly interact with each other and form a Kinase complex that positively or
negatively regulates different targeted gene transcription. As their role individually in
regulating HAP4 transcription factor, it seems that Srb8 is a negative regulator of HAP4;
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in glucose grown cells, Srb8 interferes with Srb10 and its expression is repressed in
fermentative growth condition.
Another mediator component Gal11 also plays an important role in Hap4
regulation. Gal11/Med15 in the mediator tail module contains four N-terminal
activator-binding domains that are crucial for interaction with transcription activators
[71, 72]. Gal11, Med2 and Med 3 form a triad which is capable of binding the promoter
region of Gcn4 activator as a free subcomplex. The entire tail module is essential for
recruitment and stabilization of mediator complex to Gcn4p[73]. Western analyses and
column binding assays show that Gal11 directly interacts with gene-specific
transcriptional activators[74]. Not only Gal11 required for interaction of mediator
complex and gene-specific transcription activator, but it also required for the efficient
recruitment of RNA polymerase II holoenzyme to a promoter via activator-specific
interactions for transcriptional repression or derepression of many genes[75] . In Hap4
regulation, it is reasonable to believe that the activator-binding domain of Gal11 directly
binds to the Hap4 transcription factor and positively regulates HAP4 promoter activity,
by interfering with Med3 subunit which is not absolutely required.

Overall, both amino acids signaling pathways for nitrogen-based nutrient
sensing and mitochondria biogenesis metabolism for carbon source sensing are very
important in yeast growth. By using S. cerevisiae as a model and studying its cellular
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mechanism responding to different nutrient sources can help us understand the overall
physiological system of sensing and utilizing nutrient in eukaryotes.

FUTURE WORK
Genomic DNAs of three unknown cysteine-resistant mutants have been generated and
will be sequenced to pinpoint the mutations behind the cysteine resistance phenotype.
Once the mutated genes are revealed, studies will be directed to understand the role of
these genes in cysteine toxicity. My results have shown that Srb8 processing does not
require the 26S proteasome. The underlying mechanism of Srb8 processing will be
studied.
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APPENDIX
Stain

Genotype

MCY106

MATa ura3∆ leu2∆ his3∆ met15∆ med1::kanMX4 HAP4-lacZ

MCY107

MATa ura3∆ leu2∆ his3∆ met15∆ med9::kanMX4 HAP4-lacZ

MCY108

MATa ura3∆ leu2∆ his3∆ met15∆ srb5::kanMX4 HAP4-lacZ

MCY109

MATa ura3∆ leu2∆ his3∆ met15∆ srb11::kanMX4 HAP4-lacZ

MCY112

MATa ura3∆ leu2∆ his3∆ met15∆ sin4::kanMX4 HAP4-lacZ

MCY205

MATa ura3∆ leu2∆ his3∆ met15∆ srb8::kanMX4 HAP4-lacZ [pMC139]

MCY206

MATa ura3∆ leu2∆ his3∆ met15∆ srb9::kanMX4 HAP4-lacZ [pMC141]

MCY208

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC144]

MCY209

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC146]

MCY210

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC158]

MCY211

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC148]

MCY212

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC160]

MCY213

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC162]

MCY214

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC150]

MCY215

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC152]

MCY229

MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pZL1634]

MCY230

MATa ura3∆ leu2∆ his3∆ met15∆ srb8::kanMX4 HAP4-lacZ [pZL1634]

MCY231

MATa ura3∆ leu2∆ his3∆ met15∆ srb9::kanMX4 HAP4-lacZ [pZL1634]

MCY232

MATa ura3∆ leu2∆ his3∆ met15∆ srb10::kanMX4 HAP4-lacZ [pZL1634]

MCY240
MCY306
MCY242
MCY307
MCY243
MCY308
MCY244
MCY310
MCY245
MCY311
MCY246
MCY320
MCY247
MCY321
MCY248
MCY322
MCY249
MCY323
MCY250
MCY328
MCY251
MCY329
MCY252
MCY331
MCY253
RBY98661
MCY254
DCY125
MCY257
ZLY043
MCY258
ZLY034
MCY259
ZLY1940
MCY260
ZLY2816

MATa ura3∆
ura3∆ leu2∆
leu2∆ his3∆
his3∆ met15∆
met15∆ srb10::kanMX4
HAP4-lacZ [pMC142]
MATa
HAP4-lacZ [pMC148]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC164]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC201]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC155]
MATa ura3∆ leu2∆ his3∆ met15∆ med5::kanMX4 HAP4-lacZ [pMC179]
MATa ura3∆ leu2∆ his3∆ met15∆ med3::kanMX4 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆-13u3 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆ med5::kanMX4 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆-13u3 HAP4-lacZ [pMC139]
MATa ura3∆ leu2∆ his3∆ met15∆ med5::kanMX4 HAP4-lacZ [pMC179]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC172]
MATa ura3∆ leu2∆ his3∆ met15∆ gal11::kanMX4 HAP4-lacZ [pMC201]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC167]
MATa ura3∆ leu2∆ his3∆ met15∆ med31::kanMX4 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC227]
MATa ura3∆ leu2∆ his3∆ met15∆ med31::kanMX4 HAP4-lacZ [pMC227]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC180]
MATa ura3∆ leu2∆ his3∆ met15∆ med20::kanMX4 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆ erg6::kanMX4 [pMC139]
MATa ura3∆ leu2∆ his3∆ met15∆ med20::kanMX4 HAP4-lacZ [pMC172]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC233]
MATa ura3∆ leu2∆ his3∆ met15∆ med3::kanMX4 HAP4-lacZ [pMC180]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC243]
MATa ura3∆ leu2∆ his3∆ met15∆ med19::kanMX4 HAP4-lacZ [pMC170]
MATa ura3 iAGP1-lacZ-kanMX4
MATa ura3∆ leu2∆ his3∆ met15∆ gal11::kanMX4 HAP4-lacZ [pZL1634]
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC226]
MATα ura3-52 lys2-201 iAGP1-lacZ
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC205]
MATα ura3-52 AGP1-lacZ dal81-6
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC206]
MATα ura3 lys2 AGP1-lacZ ssy5::kanMX4
MATa ura3∆ leu2∆ his3∆ met15∆ HAP4-lacZ [pMC208]
MATα lys2 iAGP1-lacZ ssy1
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ZLY3163

MATα ura3 lys2 ptr3 ssy5 iAGP1-lacZ::kanMX4

RBY98217

MATα ura3 leu2 lys2 rtg2::LEU2 shr3::URA3-4

Table 2: Plasmids used in this study
Plasmid

Plasmid description

pMC142

pRS415-ADH1p-SRB10-Amyc

pMC139

pRS415-ADH1p-SRB8-Amyc-his12

pMC141

pRS415-ADH1p-SRB9-Amyc-his12

pMC201

pRS415-GAL11-myc

pMC162

pRS415-MED10-myc

pMC150

pRS415-MED11-myc

pMC164

pRS415-MED14-myc

pMC215

pRS415-MED17-myc

pMC170

pRS415-MED19-myc

pMC172

pRS415-MED20-myc

pMC152

pRS415-MED21-myc

pMC155

pRS415-MED22-myc

pMC144

pRS415-MED2-myc
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pMC167

pRS415-MED31-myc

pMC180

pRS415-MED3-myc

pMC146

pRS415-MED4-myc

pMC179

pRS415-MED5-myc

pMC158

pRS415-MED6-myc

pMC148

pRS415-MED7-myc

pMC160

pRS415-MED8-myc

pTP479

pRS415-MED1-HA

pTP501

pRS415-MED9-HA

pMC101

pRS415-SIN4-HA

pTP507

pRS415-SRB11-HA

pTP504

pRS415-SRB5-HA

pMC205

pRS425-MED4-myc

pMC206

pRS425-MED10-myc

pMC208

pRS425-MED20-myc

pMC227

pRS425-MED31-myc

pMC233

pRS425-MED3-myc

pMC243

pRS425-GAL11-myc

pMC226

pRS425-ADH1p-Ala10-myc

pWCJ-HAP4p-lacZ

pWCJ-HAP4p-lacZ

pZL1634

pRS415-ADH1p-myc3 (vector)

B1254

pRS416-STP1p-STP1C

B1306

pRS417-GPD1-STP1-myc3-2
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